- Home
- MOGU vs KZIA Comparison
MOGU vs KZIA Comparison
Compare MOGU & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- KZIA
- Stock Information
- Founded
- MOGU 2011
- KZIA 1994
- Country
- MOGU China
- KZIA Australia
- Employees
- MOGU N/A
- KZIA N/A
- Industry
- MOGU Business Services
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- KZIA Health Care
- Exchange
- MOGU Nasdaq
- KZIA Nasdaq
- Market Cap
- MOGU 18.7M
- KZIA 18.7M
- IPO Year
- MOGU 2018
- KZIA 1999
- Fundamental
- Price
- MOGU $2.33
- KZIA $3.05
- Analyst Decision
- MOGU
- KZIA Strong Buy
- Analyst Count
- MOGU 0
- KZIA 1
- Target Price
- MOGU N/A
- KZIA $20.00
- AVG Volume (30 Days)
- MOGU 4.5K
- KZIA 85.9K
- Earning Date
- MOGU 01-03-2025
- KZIA 01-03-2025
- Dividend Yield
- MOGU N/A
- KZIA N/A
- EPS Growth
- MOGU N/A
- KZIA N/A
- EPS
- MOGU N/A
- KZIA N/A
- Revenue
- MOGU $19,801,126.00
- KZIA $1,655,324.00
- Revenue This Year
- MOGU N/A
- KZIA $806.89
- Revenue Next Year
- MOGU N/A
- KZIA N/A
- P/E Ratio
- MOGU N/A
- KZIA N/A
- Revenue Growth
- MOGU N/A
- KZIA 248000.00
- 52 Week Low
- MOGU $1.62
- KZIA $1.90
- 52 Week High
- MOGU $3.58
- KZIA $15.80
- Technical
- Relative Strength Index (RSI)
- MOGU 59.92
- KZIA 30.94
- Support Level
- MOGU $2.17
- KZIA $2.78
- Resistance Level
- MOGU $2.49
- KZIA $4.20
- Average True Range (ATR)
- MOGU 0.14
- KZIA 0.55
- MACD
- MOGU 0.03
- KZIA -0.13
- Stochastic Oscillator
- MOGU 91.07
- KZIA 9.92
About MOGU MOGU Inc. (each representing 25)
MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.